Antibiotics should not be used as a treatment at all; nobody should take an antibiotic for any reason (not even after a tooth extraction); the body can cope on its own.
Original statement
مش محتاج مضاد حيوي خالص انا لا اؤمن بالمضاد الحيوي كوسيله علاج نهائيا
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Antibiotics should not be used as a treatment at all; nobody should take an antibiotic for any reason (not even after a tooth extraction); the body can cope on its own.
Origin
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr.D Clinics - Diaa Al Awady is live! الالتهاب الخلوي ❤️❤️❤️ (Open source)
- Published
- 25 May 2025
- Timestamp
- 0:48:05 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps; 'published' is the date listed by the archive. Passage read in context.
- Claimed mechanism
The body heals itself; antibiotics harm the microbiome.
- Claimed health effect
Antibiotics unnecessary/harmful in all cases.
- Population concerned
Everyone, including patients with infections
- Geographic restriction by Elawady
none found
Diverging source versions
انا قلت ما حدش ياخد مضاد حيوي لاي سبب من الاسباب حتى كنت زمان بقول اللي هيزرع درس او هيشيل درس ياخد قرص واحد لا ما تاخدش كنت غلطان ما تاخدش خالص
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! الأكل وراء كل مشاكلك (Open source)
- Published
- 20 July 2025
- Timestamp
- 0:49:36 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps; 'published' is the date listed by the archive. Passage read in context.
حتى لو سبق ل فيديوهات قديمه وقلت فيها خد قرص ولا قرصين ما تاخدش ما تاخدش جسمك قادر
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr.D Clinics - Diaa Al Awady is live! الالتهاب الخلوي ❤️❤️❤️ (Open source)
- Published
- 25 May 2025
- Timestamp
- 0:48:32 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps; 'published' is the date listed by the archive. Passage read in context.
سالته انه ياخد مضاد حيوي وادويه السكر قال لي ولا ياخد اي حاجه دي كلها موت
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- حاله من وعي وحصار الأصحاء لجهل الاطباء (Open source)
- Published
- 25 March 2026
- Timestamp
- 0:00:35 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Conversation with patients/relatives; Elawady recounts that he advised a hospitalised patient (blood glucose reported as 700) to take neither antibiotics nor diabetes drugs and to leave hospital on own responsibility.
بس ده مش معناه برض ان انا بقول مضاد الحوي مالوش لازمه
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- الجزء التالت من الندوة (Open source)
- Published
- 2 March 2024
- Timestamp
- 0:04:26 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Earlier (2024) seminar: a more moderate statement - 'this does not mean I say antibiotics are useless'. Recorded for fairness; later videos (2025) explicitly retract earlier moderate advice.
- Source status
- Archive editors
- Attribution
- Archive editors (eltayebat.com)
- Origin
- https://eltayebat.com/rule/antibiotic-overuse/
- Attribution uncertainty
- The archive itself takes a different position: 'Antibiotics save lives when used for confirmed bacterial infections ... The answer is not to abandon antibiotics; it is to reserve them for the infections that genuinely demand them.' This contradicts Elawady's transcript statements.
ياس يا جبله [موسيقى] ماحدش ياخد يا جماعه مضادات حيويه >> ماحدش ياخد مضادات حيويه يا جماعه >> والله العظيم خدعه ورب الكعبه خدعه يا جماعه ما حدش ياخد اعشاب ولا مضادات
Nobody should take antibiotics (or herbs); antibiotics are a deception.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live!صباح الخير اتباع العوضي (Open source)
- Published
- 19 September 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
Scientific assessment
False – The statement contradicts the robust evidence.
Certainty of evidence: high – Further research is very unlikely to change the assessment.
1. What was claimed?
Antibiotics should never be used.
2. What is demonstrably correct?
Many antibiotic prescriptions are unnecessary (A-ABX-19). For acute otitis media in children, antibiotics reduce pain only modestly (NNTB 20 at 2-3 days) and cause side effects (NNTH 14); serious complications were rare in both groups (I-ABX-09). In mild respiratory infections, delayed or no antibiotics gave similar outcomes for many symptoms with no difference in complications, and cut antibiotic use from 93% to 30% (I-ABX-101). So 'often not needed' is correct for some mild infections.
3. What is wrong or exaggerated?
A blanket refusal is contrary to strong evidence. In septic shock, each hour of delay in effective antimicrobial therapy was associated with an average 7.6% decrease in survival (I-ABX-08); in 49,331 sepsis patients, each hour of delay increased risk-adjusted mortality (OR 1.04 per hour) (I-ABX-07); a meta-analysis found lower mortality with antibiotics within 1 hour in septic shock (I-ABX-103). In randomised trials in young children with mild (fast-breathing) pneumonia, amoxicillin reduced treatment failure compared with no antibiotic (RR 0.84, 0.75-0.94; I-ABX-102). The Surviving Sepsis Campaign (I-ABX-104), NICE (sepsis in adults and children, meningitis, pneumonia) and WHO (I-ABX-105) all require prompt antibiotics for serious bacterial infections. The AMR burden studies (A-ABX-18, I-ABX-01) count deaths that occur because antibiotics no longer work, and the GBD authors estimate that better care including 'improved access to antibiotics' could avert 92.0 million deaths between 2025 and 2050 (I-ABX-01). Even the archive that hosts his material states that antibiotics 'save lives'.
4. What remains unclear?
None regarding the core point.
5. Which studies support it?
Only for the limited correct part (overuse; mild infections): A-ABX-19, I-ABX-09, I-ABX-101.
6. Which studies contradict it?
I-ABX-07, I-ABX-08, I-ABX-102 (children, RCTs), I-ABX-103, I-ABX-104 (Surviving Sepsis 2021), I-ABX-105 (WHO AWaRe), I-ABX-01, A-ABX-18; NICE NG253, NG254, NG240, NG250.
7. What applies to Germany and Europe?
Standard care in Germany/EU and the UK: antibiotics within 1 hour for high-risk sepsis in adults and children (NICE NG253/NG254) and for suspected bacterial meningitis (NICE NG240), within 4 hours for community-acquired pneumonia in hospital (NICE NG250); stewardship to avoid unnecessary use.
8. What is known about Egypt?
Same medical standard; overuse is common in Egyptian private primary care (antibiotics in 81.2% of infection consultations; I-ABX-131) and the regional AMR burden is high (I-ABX-02), which makes appropriate use more, not less, important.
9. What practical conclusion is appropriate?
Never refuse or stop antibiotics prescribed for a serious bacterial infection without medical advice. Unnecessary antibiotics should be avoided.
Assessment details
- Rationale for certainty of evidence
Strong, consistent evidence that timely antibiotics reduce mortality in serious bacterial infections (sepsis/septic shock), plus the large burden of deaths from resistant (i.e. effectively untreatable) infections. It is correct that many minor infections (e.g. acute otitis media in high-income settings) often resolve without antibiotics.
- Source quality
Machine transcripts of live talks; statement is categorical and repeated.
- Regional transferability
Universal.
- Individual exceptions
In mild, self-limiting infections antibiotics are often unnecessary; this is a case-by-case medical decision.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Scientifically refuted – High-quality evidence shows the opposite, or the claim contradicts well-established physiology.
Research question: In people with bacterial infections (including serious infections such as sepsis, pneumonia and meningitis, and in children), does avoiding antibiotics altogether lead to outcomes as good as appropriate antibiotic treatment?
Research question in detail (PICO)
- Population
- Children and adults with bacterial infections, from mild respiratory infections to sepsis, pneumonia and meningitis
- Intervention or exposure
- No antibiotics / refusal ('the body can cope')
- Comparison
- Guideline-based antibiotic treatment (immediate or delayed as appropriate)
- Geographic scope
- Universal biology; care standards similar in Europe and Egypt
- Outcomes
- Mortality
- Treatment failure
- Complications
- Antibiotic use
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
Many mild chest, ear and throat infections can be managed without immediate antibiotics
Spurling GK et al.. Cochrane Database Syst Rev 2023 · PMID 37791590 · DOI 10.1002/14651858.CD004417.pub6 Systematic reviewabstract checkednewly addedCochrane review of 12 RCTs in mild respiratory infections.
- Actual result
- Similar outcomes with delayed/no antibiotics for many symptoms; no difference in complications (low certainty); antibiotic use 30% vs 93%.
- Methodological quality
- high
- Relevance
- indirect: mild infections only
- Limitations
- Excludes serious infections.
Antibiotics for children's ear infections (Cochrane 2023)
Venekamp RP et al.. Cochrane Database Syst Rev 2023 · PMID 37965923 · DOI 10.1002/14651858.CD000219.pub5 Systematic reviewabstract checkedCochrane review, acute otitis media in children.
- Actual result
- Pain at 2-3 days NNTB 20; adverse effects NNTH 14; serious complications rare in both groups.
- Methodological quality
- high
- Relevance
- indirect: mild infection
Unnecessary antibiotic prescriptions in the US
Fleming-Dutra KE et al.. JAMA 2016 · PMID 27139059 · DOI 10.1001/jama.2016.4151 Cross-sectional studyabstract checkedUS national survey.
- Actual result
- About 30% of outpatient prescriptions unnecessary.
- Methodological quality
- high
- Relevance
- indirect: overuse, not refusal
What speaks against the claim?
International sepsis guideline: give antibiotics immediately
Evans L et al.. Intensive Care Med 2021 · PMID 34599691 · DOI 10.1007/s00134-021-06506-y Guideline / position statementabstract checkednewly addedSurviving Sepsis Campaign 2021.
- Actual result
- Strong recommendation: antimicrobials immediately, ideally within 1 h, in possible septic shock.
- Methodological quality
- high (international GRADE guideline)
- Relevance
- direct
- Limitations
- Timing evidence low quality.
Antibiotics help children with pneumonia
Gadapani Pathak B et al.. J Glob Health 2026 · PMID 42725565 · DOI 10.7189/jogh.16.04209 Meta-analysisfull text checkednewly addedMeta-analysis of 4 RCTs in children with fast-breathing pneumonia.
- Actual result
- Amoxicillin vs no antibiotic: treatment failure RR 0.84 (0.75-0.94); largest trial RD 2.3 points (NNT about 43).
- Methodological quality
- high (RCTs; full text read)
- Relevance
- direct: children, no-antibiotic comparison
- Limitations
- Mild pneumonia; LMICs.
Antibiotic timing in septic shock
Kumar A et al.. Crit Care Med 2006 · PMID 16625125 · DOI 10.1097/01.CCM.0000217961.75225.E9 Cohort studyabstract checkedSeptic shock cohort (Kumar 2006).
- Actual result
- Each hour of delay in effective antimicrobials associated with an average 7.6% decrease in survival.
- Methodological quality
- moderate (observational)
- Relevance
- direct
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
Refusing antibiotics in all cases is contrary to strong, consistent evidence and to every guideline found (WHO, NICE, Surviving Sepsis). The correct part is that many mild respiratory infections, such as colds and many ear and throat infections, resolve without antibiotics and that antibiotics are overused.
Why some studies weigh more
Guidelines and RCT/meta-analytic evidence on serious infections weigh most for the harm question; evidence on mild infections answers a different question (when antibiotics can be avoided safely).
Is a causal relationship established? Yes, established Antibiotics kill bacteria; untreated bacterial sepsis, meningitis and pneumonia have high mortality; RCTs show benefit even in mild childhood pneumonia, and delay in septic shock is associated with higher mortality.
Remaining uncertainty
Exact benefit per hour of delay in sepsis without shock; which children with mild pneumonia can safely go without antibiotics.
Justified conclusion
Blanket refusal of antibiotics is unsafe; stewardship (use when needed) is correct.
Why do studies seem to disagree?
No true conflict: trials showing that delayed or no antibiotics are safe concern mild, self-limiting respiratory infections in selected patients (I-ABX-101, I-ABX-09), whereas timing and RCT evidence in sepsis and pneumonia concerns infections where antibiotics prevent death or treatment failure (I-ABX-102-104, I-ABX-07, I-ABX-08). In children, an individual 1-hour antibiotic target was not independently significant in one New York cohort (Evans 2018, JAMA, PMID 30043064, abstract read), but completing the whole 1-hour bundle including antibiotics was associated with lower mortality; this concerns minutes-to-hours timing, not refusal.
Does this depend on the country?
- General biological effects
- Universal biology.
- Eating habits
- Not applicable (medicine use, not diet).
- Legal rules
- Antibiotics are prescription medicines in the EU; non-prescription dispensing is common in Egypt and other LMICs.
- Actual monitoring data
- Egypt: antibiotics in 81.2% of infection consultations in private primary care (I-ABX-131) - overuse is real there too, which argues for stewardship, not refusal.
A regional difference that changes the conclusion is not supported by robust data.
Statistical re-check
- NNT – Jehan 2020: RD 2.3 points -> NNT 43 (27-111); pooled RR 0.84 (0.75-0.94) log-symmetric. recalculated
- Per-hour odds – OR 1.04 per hour -> about 1.27 after 6 hours (multiplicative approximation). recalculated
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Mortality/treatment failure without antibiotics in serious bacterial infections
- Starting level
- high (randomised trials)
- Reasons for downgrading
- indirectness for some timing data (comparisons of earlier vs later treatment, not none)
- Reasons for upgrading
- large effect in untreated serious infection
- consistency across guidelines and designs
- Result
- high
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Clinical guidelines and official statements checked
- Surviving Sepsis Campaign (SCCM/ESICM): International guidelines for management of sepsis and septic shock 2021 (2021) · Original publication
Administer antimicrobials immediately, ideally within 1 h, for possible septic shock or high likelihood of sepsis (strong recommendation); within 3 h for possible sepsis without shock if concern persists (weak). - NICE: NG253 Suspected sepsis in people aged 16 or over: recognition, assessment and early management (published 19 Nov 2025, updated 23 Sep 2026) (2026) · Original publication
Give people aged 16 or over at high risk of severe illness or death from sepsis broad-spectrum intravenous antibiotics within 1 hour of calculating the NEWS2 score on initial assessment or deterioration; GPs in remote areas should be able to give antibiotics before transfer. - NICE: NG254 Suspected sepsis in under 16s: recognition, diagnosis and early management (published 19 Nov 2025) (2025) · Original publication
For children and young people under 16 with any high-risk criterion: give a broad-spectrum antimicrobial without delay (within 1 hour of identifying high-risk criteria) and transfer immediately; babies under 3 months receive an additional antibiotic active against listeria (antibiotic chapter). - NICE: NG240 Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (19 Mar 2024) (2024) · Original publication
Transfer people with suspected bacterial meningitis or meningococcal disease to hospital as an emergency; give intravenous antibiotics as soon as bacterial meningitis is suspected, within 1 hour of arrival; give ceftriaxone or benzylpenicillin before arrival for strongly suspected meningococcal disease if this does not delay transfer. - NICE: NG250 Pneumonia: diagnosis and management (2 Sep 2025; replaces NG138) (2025) · Original publication
Start antibiotic treatment as soon as possible after diagnosing community-acquired pneumonia, and within 4 hours of presentation to hospital. - WHO: The WHO AWaRe (Access, Watch, Reserve) antibiotic book (2022) · Original publication
Inappropriate use and overuse of antibiotics drive AMR; the book gives evidence-based guidance on antibiotic choice, dose, route and duration for over 30 common infections in children and adults. - CDC: Core Elements of Outpatient Antibiotic Stewardship (2016) · Original publication could not be retrieved; content not used
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| Europe PMC | 26 October 2026 | ("delayed antibiotic" OR "no antibiotic" OR "antibiotic prescribing strategies") AND ("respiratory tract infection" OR "respiratory infections") AND (SRC:MED) AND (PUB_TYPE:"Systematic Review" OR JOURNAL:"Cochrane Database Syst Rev" OR TITLE:"meta-analysis") | supporting evidence | 1621 | |
| Europe PMC | 26 October 2026 | ("reduced antibiotic prescribing" OR "lower antibiotic prescribing") AND (pneumonia OR "peritonsillar abscess" OR complications) AND (safety) AND (primary care) AND SRC:MED | supporting evidence | 121 | |
| Europe PMC | 26 October 2026 | TITLE:"Delayed antibiotic prescriptions for respiratory infections" | supporting evidence | 1 | |
| Europe PMC | 26 October 2026 | TITLE:"Safety of reduced antibiotic prescribing for self limiting respiratory tract infections" | supporting evidence | 1 | |
| Europe PMC | 26 October 2026 | DOI:"10.1002/14651858.CD004417.pub6" | supporting evidence | 1 | |
| PubMed | 26 October 2026 | ("Respiratory Tract Infections"[MeSH] AND "Anti-Bacterial Agents"[MeSH]) AND (placebo[tiab] OR "no antibiotic"[tiab]) AND (Cochrane Database Syst Rev[ta]) | supporting evidence | 101 | |
| Europe PMC | 26 October 2026 | (sepsis OR "septic shock") AND ("time to antibiotics" OR "antibiotic timing" OR "delay") AND (mortality) AND (PUB_TYPE:"Systematic Review" OR TITLE:"meta-analysis") AND PUB_YEAR:[2019 TO 2026] | contradicting evidence | 1211 | |
| PubMed | 26 October 2026 | (sepsis[ti] OR "septic shock"[ti]) AND (antibiotic*[ti] OR antimicrobial*[ti]) AND (timing[ti] OR delay*[ti] OR "time to"[ti]) AND (meta-analysis[pt] OR systematic review[pt]) | contradicting evidence | 4 | |
| Europe PMC | 26 October 2026 | (pediatric OR paediatric OR children) AND sepsis AND ("time to antibiotic" OR "antibiotic delay" OR "hour" ) AND (mortality) AND (bundle OR antibiotics) AND PUB_YEAR:[2014 TO 2026] AND (JOURNAL:"JAMA" OR JOURNAL:"Crit Care Med" OR JOURNAL:"Pediatrics" OR JOURNAL:"Lancet*") | contradicting evidence | 50 | |
| Europe PMC | 26 October 2026 | (bacterial meningitis) AND (antibiotic OR antimicrobial) AND (delay OR "door-to-antibiotic") AND (mortality OR "unfavourable outcome" OR "unfavorable outcome") AND (cohort OR "systematic review") | contradicting evidence | 2923 | |
| Europe PMC | 26 October 2026 | TITLE:"New York Sepsis Care Mandate" AND TITLE:"Pediatric" | contradicting evidence | 1 | |
| Europe PMC | 26 October 2026 | (placebo) AND (amoxicillin) AND ("fast breathing" OR "fast-breathing" OR "nonsevere pneumonia" OR "non-severe pneumonia") AND (children OR infants) AND (randomized OR randomised) | both directions | 118 | |
| PubMed | 26 October 2026 | (pneumonia[ti]) AND (children[ti] OR child*[ti]) AND (placebo[ti] OR "no antibiotic"[ti] OR "without antibiotics"[ti]) | both directions | 30 | |
| Europe PMC | 26 October 2026 | (untreated OR "no antibiotic" OR "pre-antibiotic era" OR "preantibiotic era") AND (pneumococcal bacteremia OR "bacterial meningitis" OR "pneumococcal pneumonia") AND (mortality OR "case fatality") | contradicting evidence | 14310 | |
| Europe PMC | 26 October 2026 | TITLE:"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021" | guidelines | 5 | |
| Web (curl, who.int) | 26 October 2026 | https://www.who.int/publications/i/item/9789240062382 | guidelines | 1 | |
| Web (curl, nice.org.uk) | 26 October 2026 | https://www.nice.org.uk/guidance/ng253/chapter/Managing-suspected-sepsis ; https://www.nice.org.uk/guidance/ng254/chapter/Managing-suspected-sepsis ; https://www.nice.org.uk/guidance/ng240/chapter/Recommendations ; https://www.nice.org.uk/guidance/ng250/chapter/Recommendations | guidelines | 4 |
Open questions
Egyptian data on outcomes of patients who refuse antibiotics.
How deeply was this checked?
11 linked studies: 4 checked in full text (2 of them with a structured risk-of-bias assessment), 7 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: False (high)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: False (high)
New guidelines (NICE 2024-2026, WHO) and a 2026 meta-analysis of RCTs in children confirm the verdict; Cochrane evidence on mild infections confirms the limited correct part. No change needed; bottom line made explicit and safety note sharpened.
New sources: I-ABX-101 I-ABX-102 I-ABX-103 I-ABX-104 I-ABX-105
In plain language
Dr Elawady said that nobody should take antibiotics for any reason and that the body can cope by itself. This is wrong and dangerous. In severe infections like sepsis, every hour of delay in antibiotic treatment increases the risk of death. It is true that many minor infections, like many ear infections in children, often heal without antibiotics, and that antibiotics are overused. The correct approach is to use antibiotics when they are needed, not never.
Studies on this claim
Studies supporting the claim (2)
-
Unnecessary antibiotic prescriptions in the US
Fleming-Dutra KE et al.. JAMA 2016 · PMID 27139059 · DOI 10.1001/jama.2016.4151Cross-sectional studycited by the Tayebat archiveabstract checked★ key studyAbout 30% of outpatient antibiotic prescriptions were judged unnecessary.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Estimate inappropriate use.
- How was the study done?
Survey analysis.
- How many people, animals or samples were studied?
184,032 visits.
- What was actually found?
30% inappropriate.
- How large was the observed effect?
506 vs 353/1000.
- What do the results mean in everyday life?
Overuse is common.
- What are the study's limitations?
Estimated appropriateness.
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Low.
- What can explicitly not be concluded from this study?
That antibiotics are never needed.
-
Antibiotics for children's ear infections (Cochrane 2023)
Venekamp RP et al.. Cochrane Database Syst Rev 2023 · PMID 37965923 · DOI 10.1002/14651858.CD000219.pub5Systematic reviewindependent cross-checkabstract checked★ key studyAntibiotics helped only a little with pain and caused side effects; serious complications were rare either way.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Assess antibiotics in AOM.
- How was the study done?
Cochrane review.
- How many people, animals or samples were studied?
13 RCTs.
- What was actually found?
Small benefit, some harm.
- How large was the observed effect?
NNTB 20, NNTH 14.
- What do the results mean in everyday life?
Many ear infections heal alone.
- What are the study's limitations?
High-income only.
- What does it say about Elawady's specific claim?
Supports 'often unnecessary', not 'never'.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Serious infections.
No study in this group is marked as key.
Studies contradicting or limiting the claim (8)
-
Faster antibiotics in sepsis save lives
Seymour CW et al.. N Engl J Med 2017 · PMID 28528569 · DOI 10.1056/NEJMoa1703058Cohort studyindependent cross-checkfull text, structured risk-of-bias assessment★ key studyEach hour of delay in antibiotics was linked to about 4% higher odds of death.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Assess timing.
- How was the study done?
Cohort.
- How many people, animals or samples were studied?
49,331 sepsis patients in 149 New York hospitals (2014-2016).
- What was actually found?
Each hour of delay to antibiotics was linked to 4% higher odds of dying in hospital; delay from 1 to 6 hours to complete the bundle meant about 3 percentage points more deaths. Faster IV fluids showed no clear effect.
- How large was the observed effect?
OR 1.04 per hour.
- What do the results mean in everyday life?
Antibiotics are vital in sepsis.
- What are the study's limitations?
Observational; antibiotic appropriateness unknown; one US state.
- What does it say about Elawady's specific claim?
Contradicts 'never antibiotics'.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Exact causal size of benefit per hour; applies to sepsis, not to minor infections.
-
Antibiotic timing in septic shock
Kumar A et al.. Crit Care Med 2006 · PMID 16625125 · DOI 10.1097/01.CCM.0000217961.75225.E9Cohort studyindependent cross-checkabstract checkedEach hour of delay reduced survival by about 7.6% on average.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Assess delay.
- How was the study done?
Cohort.
- How many people, animals or samples were studied?
2154 patients.
- What was actually found?
Delay worsens survival.
- How large was the observed effect?
-7.6% per hour.
- What do the results mean in everyday life?
Antibiotics are life-saving here.
- What are the study's limitations?
Retrospective.
- What does it say about Elawady's specific claim?
Contradicts claim.
- Do the results apply to Germany and Europe?
High.
-
Antibiotic resistance deaths 1990-2050
GBD 2021 Antimicrobial Resistance Collaborators. Lancet 2024 · PMID 39299261 · DOI 10.1016/S0140-6736(24)01867-1Risk assessmentindependent cross-checkfull text, structured risk-of-bias assessment★ key studyAbout 1.14 million deaths were caused by resistance in 2021; better care and access to antibiotics could prevent tens of millions of deaths.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Track AMR burden.
- How was the study done?
GBD modelling.
- How many people, animals or samples were studied?
520 million records.
- What was actually found?
2021: 1.14 million deaths caused by resistance and 4.71 million deaths with a resistant infection; deaths in children under 5 fell by more than half since 1990, but rose by over 80% in people 70 and older.
- How large was the observed effect?
1.91 M forecast for 2050.
- What do the results mean in everyday life?
Resistance is rising; access to the right antibiotics matters.
- What are the study's limitations?
Model estimates; little data in many poorer countries; forecasts depend on assumptions.
- What does it say about Elawady's specific claim?
Supports burden; contradicts refusing antibiotics.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Exact counts.
-
Global deaths from antibiotic resistance (2019)
Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0Risk assessmentcited by the Tayebat archivefull text checked★ key studyAbout 1.27 million deaths were directly caused by resistant bacteria in 2019.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Estimate AMR burden.
- How was the study done?
Global modelling.
- How many people, animals or samples were studied?
471 million records.
- What was actually found?
1.27 M attributable, 4.95 M associated deaths.
- How large was the observed effect?
Regional rates 6.5-27.3/100,000.
- What do the results mean in everyday life?
Resistance is a leading killer.
- What are the study's limitations?
Model estimates.
- What does it say about Elawady's specific claim?
Supports burden claim; not 'combined'.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Exact counts.
-
Antibiotics help children with pneumonia
Gadapani Pathak B et al.. J Glob Health 2026 · PMID 42725565 · DOI 10.7189/jogh.16.04209Meta-analysisindependent cross-checkfull text checked★ key studyIn randomised trials of young children with mild pneumonia, amoxicillin reduced treatment failure compared with no antibiotic.
Children: amoxicillin vs no antibiotic RR 0.84 for treatment failure
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Test whether amoxicillin helps young children with mild pneumonia
- How was the study done?
Meta-analysis of 4 randomised trials
- How many people, animals or samples were studied?
7699 children aged 2-59 months
- What was actually found?
Fewer treatment failures with amoxicillin
- How large was the observed effect?
RR 0.84 (0.75-0.94); NNT about 43 in the largest trial
- What do the results mean in everyday life?
Children with pneumonia should be assessed and treated by health workers; antibiotics reduce failures
- What are the study's limitations?
Mostly mild cases in low-resource countries; one trial at high risk of bias
- What does it say about Elawady's specific claim?
Contradicts the advice that no child should receive antibiotics
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Effects in severe pneumonia (no placebo trials exist because withholding treatment would be unsafe)
-
In sepsis, antibiotics given early save lives
Ku NS et al.. Korean J Intern Med 2025 · PMID 40859809 · DOI 10.3904/kjim.2025.037Meta-analysisindependent cross-checkabstract checked★ key studyPatients with septic shock who received antibiotics within 1 hour died less often than those treated later.
Delay of antibiotics in septic shock associated with higher mortality
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Check whether antibiotic timing affects sepsis deaths
- How was the study done?
Meta-analysis of 13 observational studies
- How many people, animals or samples were studied?
79,246 patients
- What was actually found?
Earlier antibiotics linked to lower mortality, clearly in septic shock
- How large was the observed effect?
Not given numerically in abstract
- What do the results mean in everyday life?
Sepsis is an emergency; antibiotics should not be delayed or refused
- What are the study's limitations?
Observational data
- What does it say about Elawady's specific claim?
Contradicts the claim
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Exact benefit per hour in sepsis without shock
-
International sepsis guideline: give antibiotics immediately
Evans L et al.. Intensive Care Med 2021 · PMID 34599691 · DOI 10.1007/s00134-021-06506-yGuideline / position statementindependent cross-checkabstract checked★ key studyExperts recommend antibiotics within 1 hour for possible septic shock.
Strong recommendation: antimicrobials immediately, ideally within 1 h, in possible septic shock
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Set standards for sepsis care
- How was the study done?
Guideline with graded evidence
- How many people, animals or samples were studied?
Not applicable
- What was actually found?
Antibiotics within 1 hour for septic shock
- How large was the observed effect?
Strong recommendation
- What do the results mean in everyday life?
Sepsis needs emergency antibiotics
- What are the study's limitations?
Timing evidence is of low quality
- What does it say about Elawady's specific claim?
Contradicts refusing antibiotics
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Exact minute-by-minute benefit
-
WHO: use the right antibiotic when needed, avoid overuse
World Health Organization. WHO publication 2022Guideline / position statementindependent cross-checkabstract checkedWHO gives antibiotic treatment guidance for over 30 common infections and warns against overuse.
WHO treatment guidance for common infections plus stewardship against overuse
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Guide antibiotic choice worldwide
- How was the study done?
WHO guidance book
- How many people, animals or samples were studied?
Not applicable
- What was actually found?
Treat common infections appropriately; avoid overuse
- How large was the observed effect?
Not applicable
- What do the results mean in everyday life?
Antibiotics are needed for many infections, but not for every illness
- What are the study's limitations?
Only the web page was read
- What does it say about Elawady's specific claim?
Contradicts refusing all antibiotics; agrees overuse is harmful
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Exact recommendations for each infection (book not read)
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
Many mild chest, ear and throat infections can be managed without immediate antibiotics
Spurling GK et al.. Cochrane Database Syst Rev 2023 · PMID 37791590 · DOI 10.1002/14651858.CD004417.pub6Systematic reviewindependent cross-checkabstract checked★ key studyDelaying or not giving antibiotics for mild respiratory infections cut antibiotic use sharply with similar recovery and no difference in complications.
Supports 'often not needed' for mild respiratory infections; not applicable to serious bacterial infections
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Compare immediate, delayed and no antibiotics for respiratory infections
- How was the study done?
Cochrane review of 12 randomised trials
- How many people, animals or samples were studied?
3968 children and adults
- What was actually found?
Similar outcomes for many symptoms; much less antibiotic use with delay
- How large was the observed effect?
Antibiotic use 30% vs 93% (delayed vs immediate)
- What do the results mean in everyday life?
For mild coughs, colds and sore throats, waiting is often safe when a doctor judges it so
- What are the study's limitations?
Mild infections only; rare complications poorly measured
- What does it say about Elawady's specific claim?
Supports only the 'overuse' part of the claim, not 'never take antibiotics'
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Whether serious bacterial infections can be left untreated (they were not studied)
No study in this group is marked as key.
Regional context
Germany / EU
Standard care in Germany/EU and the UK: antibiotics within 1 hour for high-risk sepsis in adults and children (NICE NG253/NG254) and for suspected bacterial meningitis (NICE NG240), within 4 hours for community-acquired pneumonia in hospital (NICE NG250); stewardship to avoid unnecessary use.
Egypt
Same medical standard; overuse is common in Egyptian private primary care (antibiotics in 81.2% of infection consultations; I-ABX-131) and the regional AMR burden is high (I-ABX-02), which makes appropriate use more, not less, important.
What applies in my country?
General scientific assessment
False This claim is false and dangerous: antibiotics save lives in serious bacterial infections such as sepsis, meningitis and pneumonia, including in children; only their overuse for mild infections is a real problem.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.. Fleming-Dutra KE et al.. JAMA 2016 · PMID 27139059 · DOI 10.1001/jama.2016.4151
- Antibiotics for acute otitis media in children.. Venekamp RP et al.. Cochrane Database Syst Rev 2023 · PMID 37965923 · DOI 10.1002/14651858.CD000219.pub5
- Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.. Seymour CW et al.. N Engl J Med 2017 · PMID 28528569 · DOI 10.1056/NEJMoa1703058
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.. Kumar A et al.. Crit Care Med 2006 · PMID 16625125 · DOI 10.1097/01.CCM.0000217961.75225.E9
- Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.. GBD 2021 Antimicrobial Resistance Collaborators. Lancet 2024 · PMID 39299261 · DOI 10.1016/S0140-6736(24)01867-1
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.. Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0
- Oral amoxicillin for management of fast breathing or chest indrawing pneumonia without danger signs in children aged 2-59 months: a systematic review and meta-analysis.. Gadapani Pathak B et al.. J Glob Health 2026 · PMID 42725565 · DOI 10.7189/jogh.16.04209
- Appropriate timing of antibiotic initiation in patients with sepsis or septic shock: a systematic review and meta-analysis.. Ku NS et al.. Korean J Intern Med 2025 · PMID 40859809 · DOI 10.3904/kjim.2025.037
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.. Evans L et al.. Intensive Care Med 2021 · PMID 34599691 · DOI 10.1007/s00134-021-06506-y
- The WHO AWaRe (Access, Watch, Reserve) antibiotic book.. World Health Organization. WHO publication 2022
- Immediate versus delayed versus no antibiotics for respiratory infections.. Spurling GK et al.. Cochrane Database Syst Rev 2023 · PMID 37791590 · DOI 10.1002/14651858.CD004417.pub6